Safety and efficacy of chemosaturation in patients with primary and secondary liver tumors-Reference-Cited by-同舟云学术

Safety and efficacy of chemosaturation in patients with primary and secondary liver tumors

Published:2017-06-20 Issue:10 Volume:143 Page:2113-2121
ISSN:0171-5216
Container-title:Journal of Cancer Research and Clinical Oncology
language:en
Short-container-title:J Cancer Res Clin Oncol

Author:

Kirstein Martha M.^ORCID,Marquardt Steffen,Jedicke Nils,Marhenke Silke,Koppert Wolfgang,Manns Michael P.,Wacker Frank,Vogel Arndt

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology,General Medicine

Link

http://link.springer.com/article/10.1007/s00432-017-2461-z/fulltext.html

Reference26 articles.

1. Alexander HR Jr, Libutti SK, Pingpank JF, Bartlett DL, Helsabeck C, Beresneva T (2005) Isolated hepatic perfusion for the treatment of patients with colorectal cancer liver metastases after irinotecan-based therapy. Ann Surg Oncol 12:138–144

2. Alexander HR Jr, Bartlett DL, Libutti SK, Pingpank JF, Fraker DL, Royal R, Steinberg SM et al (2009) Analysis of factors associated with outcome in patients undergoing isolated hepatic perfusion for unresectable liver metastases from colorectal center. Ann Surg Oncol 16:1852–1859

3. BacalbaSa N, Balescu I, Dima S, Popescu I (2015) Long-term survivors after liver resection for breast cancer liver metastases. Anticancer Res 35:6913–6917

4. Blechacz BR, Gores GJ (2008) Cholangiocarcinoma. Clin Liver Dis 12:131–150, ix

5. Braat MN, Samim M, van den Bosch MA, Lam MG (2016) The role of 90Y-radioembolization in downstaging primary and secondary hepatic malignancies: a systematic review. Clin Transl Imaging 4:283–295

Cited by 30 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Hepatic chemosaturation with melphalan in patients with primary or secondary liver tumors with or without extrahepatic tumor manifestation;ESMO Gastrointestinal Oncology;2024-09

2. The Current State of Systemic Therapy of Metastatic Uveal Melanoma;American Journal of Clinical Dermatology;2024-06-22

3. Quality of Life Analysis of Patients Treated with Percutaneous Hepatic Perfusion for Uveal Melanoma Liver Metastases;CardioVascular and Interventional Radiology;2024-04-08

4. Melanoma-specific survival of patients with uveal melanoma and liver metastases diagnosed between 2005 and 2021;Therapeutic Advances in Medical Oncology;2024-01

5. The role of percutaneous hepatic perfusion (PHP) in the treatment of cholangiocarcinoma;Hepatoma Research;2024